Nachrichten zur Moderna Inc. Aktie

Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Weeks Release

Moderna (MRNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Where Will Moderna Be in 5 Years?

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and…

Moderna Aktie: Warten auf die Quartalszahlen

Moderna erreicht neues Jahres-Tief bei 21,67 Euro. Analysten halten sich mit Empfehlungen zurück, während wichtige Termine bevorstehen. Die Moderna-Aktie zeigt…

Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note

Moderna (MRNA) reachead $24.73 at the closing of the latest trading day, reflecting a -1.85% change compared to its last…

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines…

Moderna Aktie: Kursziel reduziert

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump announced a…

Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022

The first quarter of 2025 was a tough one. The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%.…

IRW-News: Moderna Inc.: Moderna präsentiert umfangreiche Forschungsarbeiten zu Infektionskrankheiten beim Weltkongress der ESCMID 2025

IRW-PRESS: Moderna Inc.: Moderna präsentiert umfangreiche Forschungsarbeiten zu Infektionskrankheiten beim Weltkongress der ESCMID 2025CAMBRIDGE, MA / ACCESS Newswire / 7.…

IRW-News: Moderna Inc.: Moderna präsentiert umfangreiche Forschungsarbeiten zu Infektionskrankheiten beim Weltkongress der ESCMID 2025

IRW-PRESS: Moderna Inc.: Moderna präsentiert umfangreiche Forschungsarbeiten zu Infektionskrankheiten beim Weltkongress der ESCMID 2025 CAMBRIDGE, MA /…

Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer…

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Markss resignation in protest of Robert F.…

Stock Movers: Moderna, Celsius, Newsmax

Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…

Why Moderna Stock Is Plummeting Today

Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The companys stock lost 7.9% as of 1:30 p.m. ET and…

Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It

Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…

4 Things You Need to Know if You Buy Moderna Stock Today

Its been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing…

2 No-Brainer Biotech Stocks to Buy Right Now

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech…

Moderna (MRNA) Advances But Underperforms Market: Key Facts

In the latest trading session, Moderna (MRNA) closed at $34.71, marking a +0.26% move from the previous day.…

2 Beaten-Down Stocks Near Their 52-Week Lows That Arent Worth Buying

Buying stocks after they have lost significant market value can lead to excellent returns in the long run, but only…

Down 93%, Is It Finally Time to Buy Moderna?

As we near the five-year anniversary of the COVID-19 pandemic, its a good time to revisit the drugmaker stock that…

Where Will Vertex Pharmaceuticals Be in 10 Years?

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first…

Insider trades: Pepsico, Moderna among notable names this week

…

President Trumps Trade War Is On. Here are 3 Things Every Investor Should Do.

After two years of double-digit gains, the S&P 500 (SNPINDEX: ^GSPC) lost its momentum -- at least temporarily -- in…

Moderna: Insider Buy Signal

…

Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday

A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price…

Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck By Investing.com

Moderna anticipates 2027 release for cancer vaccine in collaboration with Merck…

Biontech und Pfizer: Niederlage im Patentstreit mit Moderna

Moderna hat eine Klage gegen Pfizer und Biontech gewonnen. Das Unternehmen hatte den Konkurrenten vorgeworfen, Technologien kopiert zu haben. Die…

Moderna: Der CEO kauft für 5 Mio. USD Aktien. Bis 2027 sollen zehn neue Produkte auf den Markt kommen. Rebound-Chance!

Läuft es bei Moderna (MRNA) im Hintergrund gar nicht schlecht? Der Aktienkurs lässt mit seinem Dauerabsturz etwas anderes vermuten. Doch…

German court rules Pfizer, BioNTech infringed Moderna’s COVID-19 vaccine patent By Investing.com

German court rules Pfizer, BioNTech infringed Moderna’s COVID-19 vaccine patent…

German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent By Reuters

German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent…

German court rules Pfizer, BioNTech violated Modernas COVID-19 vaccine patent

A German court in Duesseldorf on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held…

Moderna shares jump on insider stock purchases

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares moved higher after it was disclosed the company insiders have purchased $6 million in shares.…

Moderna CEO Bancel buys ~$5M worth of company stock on open market

…

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a…

1 Biotech Stock to Buy in 2025, and 1 to Avoid

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.…

Eli Lillys big investment, cheaper Zepbound, and Hims & Hers options: Pharma news roundup

Plus, Modernas bird flu contract with the U.S. is being evaluated…

Why investors should stay away from Tesla and Moderna, according to one financial advisor

Courtney Garcia, senior wealth advisor at Payne Capital Management, appeared on CNBCs "Power Lunch" on Thursday to give hot takes on Tesla,…

Moderna Aktie: Einer der größten Verlierer

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Markus Bußler vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Can Modernas Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.…

Moderna: Mehr als nur COVID-19

Moderna hat sich mit seinem mRNA-Impfstoff gegen COVID-19 einen Namen gemacht, doch das Unternehmen arbeitet längst an einer breiteren…

Dow & Co unter Druck: UnitedHealth, Nvidia, Amazon, Rivian, Tesla schwach, Moderna, Alibaba stark

An den New Yorker Börsen hat sich am Freitag aufgrund von Konjunktur- und Inflationssorgen die Kursschwäche verfestigt. Der Leitindex Dow…

Dow & Co unter Druck: UnitedHealth, Nvidia, Amazon, Rivian, Tesla schwach, Moderna, Alibaba stark

An den New Yorker Börsen hat sich am Freitag aufgrund von Konjunktur- und Inflationssorgen die Kursschwäche verfestigt. Der Leitindex Dow…

Moderna stock rises amid new virus concerns By Investing.com

Moderna stock rises amid new virus concerns…

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.

In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than…

Moderna Aktie: Zwei bedeutende Rückschläge in der Medikamentenpipeline

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse der Bank of America (BofA): 1. Hintergrund der Kurszielsenkung Die BofA hat das Kursziel für die Aktie von…

Moderna has limited upside: Barclays By Investing.com

Moderna has limited upside: Barclays…

Moderna shares move higher as investors look beyond Q4 losses

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares added more than 8% during Tuesday’s session as investors remained optimistic about the company’s long-term...…

Moderna shares move higher as investors look beyond Q4 losses to pipeline potential

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares added more than 8% during Tuesday’s session as investors remained optimistic about the company’s long-term...…

This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Hims & Hers Health (NYSE:HIMS), Datadog (NASDAQ:DDOG)

…

Moderna Aktie: Downgrade nach Q4-Zahlen!

London (www.aktiencheck.de) - Moderna-Aktienanalyse von Barclays: Rating und Kursziel Barclays hat die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF,…